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Summary
Motivation: Spontaneous adverse event reports have an high potential for detecting adverse drug reactions.
However, due to their dimension, the analysis of such databases requires statistical methods. In this context,
disproportionality measures can be used. Their main idea is to project the data onto contingency tables in
order to measure the strength of associations between drugs and adverse events. However, due to the data
projection, these methods are sensitive to the problem of co-prescriptions and masking effects. Recently, lo-
gistic regressions have been used with a Lasso type penalty to perform the detection of associations between
drugs and adverse events. On different examples, this approach limits the drawbacks of the disproportional-
ity methods, but the choice of the penalty value is open to criticism while it strongly influences the results.
Results: In this paper, we propose to use a logistic regression whose sparsity is viewed as a model selection
challenge. Since the model space is huge, a Metropolis-Hastings algorithm carries out the model selection
by maximizing the BIC criterion. Thus, we avoid the calibration of penalty or threshold. During our ap-
plication on the French pharmacovigilance database, the proposed method is compared to well established
approaches on a reference data set, and obtains better rates of positive and negative controls. However, many
signals (i.e. specific drug-event associations) are not detected by the proposed method. So, we conclude
that this method should be used in parallel to existing measures in pharmacovigilance.
Availability: Code implementing the proposed method is available in R on request from the correspond-
ing author.
Key words: Binary data, logistic regression, Metropolis-Hastings algorithm, model selection, pharmacovig-
ilance, spontaneous reporting.
1 Introduction
To obtain approval, drugs go through many premarket safety tests, but adverse drug reactions may not be
detected during these experiments. Many national or international regulatory agencies have thus introduced
pharmacovigilance systems collecting spontaneously reported adverse events. Post-approval drug safety
surveillance relies on these reported cases for suspecting that some drugs induce adverse events. They pro-
vide huge binary databases that describe each individual by its drug consumption and its adverse events.
Although spontaneous reporting systems suffer from many biases (Almenoff et al., 2007), they have per-
mitted early identification of associations between drugs and adverse events (Szarfman et al., 2002). In
order to assist pharmacovigilance experts in managing such databases, statistical methods aiming to put
the light on unexpected associations have been proposed.
The most classical methods are based on disproportionality measures and use data projections onto con-
tingency tables. Among them, the most popular are: the Proportional Reporting Ratio (Evans et al., 2001),
the Reporting Odds Ratio (Van Puijenbroek et al., 2002), the Bayesian Confidence Propagation Neural
Network (Bate et al., 1998) and the Gamma Poisson Shrinkage (DuMouchel, 1999). All of these methods
∗ Corresponding author: e-mail: mohammed.sedki@u-psud.fr, Phone: +33 145 595 214
Copyright line will be provided by the publisher
2 M. Marbac, P. Tubert-Bitter, and M. Sedki:
use a specific statistic which requires a threshold for detecting associations between drugs and adverse
events. The disproportionality measure is computed for each drug-event pair in the database and compared
to the threshold. Moreover, the data projections onto the contingency tables provide good computational
performances. However, these projections involve some weakness against the problems of co-prescriptions
and masking effects from highly reported associations for some drugs (Caster et al., 2010). None of these
methods is defined as the reference approach. Due to the shortage of the gold standard sets, their compari-
son remains a challenging issue.
The shrinkage logistic regression is an interesting alternative to the methods based on data projections
onto contingency tables. In this spirit, Caster et al. (2010) propose to model the probability of an adverse
event conditionally on the drug consumptions by a sparse logistic regression whose sparsity is imposed
by a Lasso type penalty (Tibshirani, 1996). In this context, drug j and adverse event h are claimed to be
associated when the coefficient related to drug j in the regression of adverse event h is strictly positive —
since, in this case, the adverse event occurs more often with the consumption of this drug. However, the
choice of the penalty value is a crucial and very difficult task. Indeed, the penalty value directly influences
the signal detection. Caster et al. (2010) propose to use the same penalty for all the regressions. Moreover,
they set the penalty value in order to obtain the same number of signals as a disproportionality method.
A more rigorous method, but more computationally demanding, could consist in setting the penalty value
by cross-validation where the penalty is set for minimizing the misclassification error. However, as shown
during our numerical application, this approach obtains poor results notably due to the database sparsity.
Recently, Harpaz et al. (2013) have used a full logistic regression in a two-step procedure where the first
step consists in empirically selecting a subset of candidate drugs.
In this paper, the signal detection is performed by a model selection step which avoids the use of any
threshold or the calibration of the penalty. In this context, a model of a logistic regression determines
the coefficients which are not zero. In a Bayesian framework, the best model has the highest posterior
probability but this amount is not explicit. It is also useful to approximate its logarithm by the Bayesian In-
formation Criterion (Schwarz, 1978). Therefore, the signal detection consists in selecting the model which
maximizes the BIC criterion. Unfortunately, the number of competing models is too huge for applying an
exhaustive approach which computes the BIC criterion for each competing model. Therefore, the model
selection is carried out by a Metropolis-Hastings algorithm (Robert and Casella, 2004) which performs a
random walk through the models of interest. This algorithm is classically used for finding the maximum
of a function even on a discrete space. In our context, the mode of its stationary distribution corresponds
to the model maximizing the BIC criterion. Thus, we were able to develop an efficient algorithm by taking
advantage of some features of the data.
In this paper, we compare our model-based procedure to the four disproportionality methods imple-
mented in the R package PhViD and to the Lasso logistic regression implemented in the R package glmnet.
We use the database arisen from the French pharmacovigilance which received roughly 20,000 suspected
adverse drug reactions per year from 2000 to 2010. Comparison between pharmacovigilance procedures is
a difficult task. In this paper, we focus on the four adverse events described in the Observational Medical
Outcomes Partnership (OMOP) reference set (Ryan et al., 2013) and on their 145 relating drugs. To our
knowledge, it is the only reference set recently formed with positive and negative controls to address the
issue of methods assessment in pharmacovigilance.
This article is organised as follows. Section 2 presents the parsimonious version of the logistic regres-
sion. Section 3 introduces the Metropolis-Hastings algorithm devoted to the model selection. Section 4
compares the proposed method to four disproportionality methods and to the Lasso logistic regression.
Section 5 discusses the limitations and scope of the proposed approach.
Copyright line will be provided by the publisher
bimj header will be provided by the publisher 3
2 Parsimonious logistic regression
2.1 Spontaneous reporting database
Spontaneous reporting databases describe n individuals by their consumptions of p drugs and by the pres-
ence or absence of d adverse events. For the purpose of logistic regression, in this article, we consider one
adverse event at a time that we denote by the binary vector y = (y1, . . . , yn) ∈ Bn where B = {0, 1}.
More specifically, yi = 1 if individual i suffers from this adverse event and yi = 0 otherwise. In the
regression context, explanatory variables x = (x1, . . . ,xn) indicate the presence or the absence of drug
consumptions. Binary vector xi = (xi1, . . . , xip) ∈ Bp indicates the drug consumption of individual i
since xij = 1 if individual i takes drug j and xij = 0 otherwise.
2.2 Logistic regression
The probability of the adverse event given the drug consumption is assumed to follow a logit regression.
Model γ = (γ1, . . . , γp) ∈ Bp defines which drugs influence the appearance of the adverse event, since
γj = 1 if the coefficient of the regression related to drug j is unconstrained (i.e. defined on R) while
γj = 0 if this coefficient is zero. The indices of the drugs having a non-zero (respectively zero) coefficient
are grouped into the set Dγ = {j : γj = 1} (respectivelyDcγ = {j : γj = 0}).
For model γ, the logit relationship is
ln
P(yi = 1 | xi,γ,β)
1− P(yi = 1 | xi,γ,β)
= β0 +
∑
j∈Dγ
βjxij , (1)
β =
(
β0, β1, . . . , βp
)
∈ Ωγ being the vector of regression coefficients for which many coefficients are
constrained by γ to be zero, since
Ωγ =
{
β ∈ Rp+1 : ∀j ∈ Dcγ , βj = 0
}
. (2)
Thus, the drugs suspected to induce the adverse event are those belonging to Dγ and having a positive
coefficient in the regression (i.e. βj > 0).
Assuming that spontaneous reports consists of n i.i.d. observations, the adverse event log-likelihood
related to model γ is written as
ℓn
(
y | x,γ,β
)
=
n∑
i=1
yi
(
β0 +
∑
j∈Dγ
βjxij
)
− ln
[
1 + exp
(
β0 +
∑
j∈Dγ
βjxij
)]
. (3)
Obviously, the indices of xi impacting the log-likelihood value are those belonging to Dγ . In practice,
it is often more numerically efficient to compute the adverse event log-likelihood by using the unique
profiles of observations impacting the likelihood. This weighted form of the log-likelihood is described in
Appendix A.
From the database, the Maximum Likelihood Estimates (MLE) β̂γ is defined by
β̂γ = arg maxβ∈Ωγ ℓn
(
y | x,γ,β
)
. (4)
To assess (4), we need to solve the derivative likelihood equations using the classical Newton-Raphson
method (see Nocedal and Wright (2006)). However, the MLE is well defined only if the overlapping
conditions of Silvapulle (1981) are satisfied (see also the discussion of Owen and Roediger (2014)). Thus,
for the binary variables, the MLE is well defined only if
∀(hy, hx) ∈ B
2, ∀j ∈ Dγ , ∃i ∈ Ihy : xij = hx, (5)
where Ihy = {i : yi = hy}. In a few words, (5) is equivalent to have at least one absence and one presence
of drug consumption in both sets {xij | yi = 0} and {xij | yi = 1}. To ensure that the MLE is well
defined, this condition suggests us to do not take into account drugs that do not satisfy it.
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3 Model selection by MCMC algorithm
3.1 Bayesian model selection
We define the set of the competing models Γ as the set of models γ ∈ Bp where (5) is satisfied. So,
Γ = {γ ∈ Bp such as (5) is satisfied for γ}. (6)
In a Bayesian framework, the aim is to obtain the model having the highest posterior distribution p
(
γ |
y, x
)
. We assume that uniformity holds for the prior distribution p(γ | x) of models γ ∈ Γ. So, we have
p
(
γ | y, x
)
∝ p(y | x,γ), (7)
where p(y | x,γ) is the integrated likelihood defined by
p(y | x,γ) =
∫
Ωγ
p(y | x,γ,β)p(β | x,γ)dβ, (8)
where p(y | x,γ,β) = exp
(
ℓn(y | x,γ,β)
)
is the likelihood related to model γ and where p(β | x,γ) is
the prior distribution of β whose the support is included in Ωγ . Since logarithm is monotone,
arg maxγ∈Γp
(
γ | y, x
)
= arg maxγ∈Γ ln p(y | x,γ). (9)
When the integrated likelihood has not a closed form, the Bayesian Information Criterion (BIC) is
generally used. It is based on a second degree Laplace approximation of the logarithm of the integrated
likelihood (Schwarz, 1978), and it is defined as
BIC(γ) = ℓn
(
y | x,γ, β̂γ
)
−
νγ
2
lnn, (10)
where νγ = 1 +
∑p
j=1 γj is the degree of freedom for model γ. Therefore, we want to achieve γ⋆ which
is the model maximizing the BIC criterion, so
γ⋆ = arg maxγ∈ΓBIC(γ). (11)
This criterion selects the model providing the best trade-off between its accuracy related to the data and its
complexity.
Obviously, the number of competing models is too huge for applying an exhaustive approach (i.e. to
compute the BIC criterion for each model). Therefore, the Metropolis-Hastings algorithm described in the
following section is used to estimate γ⋆.
3.2 Metropolis-Hastings algorithm for achieving γ⋆
Model γ⋆ can be achieved through a Metropolis-Hastings algorithm (Robert and Casella, 2004), described
in Algorithm 1, which performs a random walk over Γ. The unique invariant distribution of Algorithm 1
is proportional to exp
(
BIC(γ)
)
. Therefore, γ⋆ is the mode of its stationary distribution.
At each iteration, the algorithm proposes to move into a neighbourhood of the current model. A neigh-
bouring model is defined as copy of the current model where just a few elements are altered. Thus, at
iteration [r], the candidate γ˜ is equal to the current model γ[r] except for α ≥ 1 elements at the maximum.
More specifically, γ˜ is uniformly sampled in Vα(γ[r]) where
Vα(γ
[r]) =

γ :
p∑
j=1
|γj − γ
[r]
j | ≤ α

 . (12)
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In the application, we set α = 5 to obtain good mixing properties. The candidate γ˜ is accepted with a
probability equal to
ρ[r] =
exp
(
BIC(γ˜)
)
exp
(
BIC(γ[r])
) . (13)
Note that we define that BIC(γ) = −∞ for all γ ∈ Bp \ Γ. This algorithm performs R iterations and
returns the model maximizing the BIC criterion. In practice, there may be almost absorbing states, so
different initialisations of this algorithm ensure to visit γ⋆.
Algorithm 1 Metropolis-Hasting performing the model selection
Initialisation γ[0] is uniformly sampled in Γ.
For r = 1, . . . , R.
Candidate step: γ˜ is uniformly sampled in Vα(γ [r]).
Acceptance/reject step: defined γ[r] with
γ[r] =
{
γ˜ with probability ρ[r]
γ[r−1] otherwise .
End For
Return arg maxr=1,...,RBIC(γ [r]).
4 Results on real data set
In this section, after presenting the French pharmacovigilance database, the proposed method is compared
to the others by using the OMOP set. Finally, specific comments are given for the proposed method.
4.1 Data
To evaluate and compare the performances of the competing methods, we use the OMOP (Ryan et al.,
2013) reference set of test cases that contains both positive and negative controls. Four adverse events
(i.e. d = 4) were studied in this reference set : acute myocardial infarction (AMI), acute kidney injury
(AKI), acute liver injury (ALI), and upper gastro-intestinal bleeding (GIB). There are three-hundred and
ninety-nine test cases where 165 positive controls and 234 negative controls were identified across the
four adverse events of interest. More details are given by Table 1. Ryan et al. (2013) indicate that the
majority of positive controls for AKI and GIB were supported by randomized clinical trial evidence, while
the majority of positive controls for ALI and AMI were only based on published case reports.
Table 1 Numbers of positive and negative controls for the four adverse event in the OMOP reference set.
control AMI GIB ALI AKI
positive 36 24 81 24
negative 66 67 37 64
Methods are compared on the data extracted from the French pharmacovigilance database where noti-
fications have been collected from 2000 to 2010. The studied database contains n = 219, 340 individuals
notifications and the consumption informations concerning p = 145 drugs mentioned on the OMOP ref-
erence set. Therefore, 145× 4 = 580 drug-event pairs are studied, among them 145 are positive controls
(25%), 153 are negative controls (26%) and 282 have an unknown status (49%). More details are given
in Table 2. The four studied adverse events occur 495 (AMI), 4746 (GIB), 10910 (ALI) and 5234 (AKI)
times in the French pharmacovigilance database.
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Table 2 Numbers of positive, negative and unknown signals for the four adverse event in the OMOP reference set
and for the 145 drugs presented in both databases (OMOP and French pharmacovigilance).
control AMI GIB ALI AKI
positive 29 20 75 21
negative 43 46 22 42
unknown 73 79 48 82
4.2 Competing methods
Disproportionality-based methods We chose to compare our method with all the disproportionality
methods implemented in the R package PhViD (Ahmed and Poncet, 2013) Thus, four disproportionality-
based methods: the Proportional Reporting Ratio (PRR), the Reporting Odds Ratio (ROR), the Reporting
Fisher Exact Test (RFET) (Ahmed et al., 2010) and the FDR-based Gamma Poisson Shrinkage (GPS)
(Ahmed et al., 2009) are considered. The specific statistics are used with a threshold of 0.05 and are
presented in Table 3. All methods are compared on the 580 drug-event pairs mentioned on the OMOP
reference set.
Table 3 Specific statistics of the disproportionality methods: statistics (Stat), minimal number of individuals having
a drug-event pair to claim this pair as a signal (Min.) and reference (Ref.).
Method Stat. Min. Ref.
PRR p-value of rank 3 Evans et al. (2001)
ROR p-value of rank 3 Van Puijenbroek et al. (2002)
RFET mid-pvalue 1 Ahmed et al. (2010)
GPS prob of H0 1 Ahmed et al. (2009)
Lasso-based logistic regressions The results of the Lasso method applied on logistic regressions are ob-
tained with the R package glmnet (Friedman et al., 2010). The penalty value is selected by cross-validation
with ten folds to obtain the most parsimonious model among the models having best misclassification er-
ror. This method permits to find few signals since the selected penalty implies that only the intercept is not
zero for only one adverse event (AMI). This example shows the difficulty for calibrating the Lasso-penalty.
Indeed, the misclassification error is roughly constant according to the penalty value. This is due to the
weak rate of notifications for one adverse event.
Model-based logistic regressions For each of the four adverse events, 100 random initialisations of
Algorithm 1 with α = 5 and R = 5.103 iterations have been done. The model maximizing the BIC
criterion is returned. Table 4 presents the number of competing models for each adverse event, which
corresponds to the dimension of Γ defined in (6).
Table 4 Number of drugs respecting (5) and number of competing models for each adverse event (|Γ|).
Adverse Event AMI GIB ALI AKI
Number of drugs respecting (5) 66 97 123 107
|Γ| 266 297 2123 2107
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4.3 Method comparison
Table 5 presents the rates of positive controls, of negative controls and of unknown signals detected by all
the competing methods.
Table 5 Main results obtained by the competing methods ordered by their rate of positive controls: number of signals
(NS), rate of positive controls (RPC), rate of negative controls (RNC) and rate of unknown signals (RUS).
Method NS RPC RNC RUS
Logistic BIC (Algorithm 1) 70 0.54 0.01 0.45
RFET 114 0.51 0.06 0.43
PRR 73 0.51 0.10 0.40
ROR 120 0.50 0.07 0.43
GPS 129 0.48 0.07 0.45
Lasso-CV 13 0.46 0.08 0.46
The proposed method obtains the best rates of positive controls and negative controls. It detects 70
signals while the Lasso-based method finds only 13 couples. The poor results of the Lasso are explained
by the penalty values assessed by the misclassification error rate. Indeed, the resulting penalty values
constrain all the coefficients to be zero for three adverse events. All the disproportionality methods obtain
similar results. Despite that many signals are detected by these methods (between 73 and 129), their rates
of positive and negative controls are worse than those resulting from the proposed method.
Since the proposed method obtains the best rates of positive and negative controls, we conclude that it is
more precise for the signal detection. However, it finds less signals than the disproportionality methods. So,
it permits the practitioner to focus on more probably related drug-event pairs. Moreover, some associations
detected only by the disproportionality method could be due to the co-prescription phenomenon.
4.4 Specific comments about the proposed method
Table 6 indicates the computing time obtained by an Intel(R) Xeon(R) CPU 3.00 GHz and the number of
times where the Algorithm 1 finds the best model.
Table 6 General results of Algorithm 1: number of times where γ⋆ has been found (model), number of signals (nb
signals), number of positive controls, number of negative controls, computing time in minutes required for one Markov
chain realization (time) and number of unique profiles for the best model (mγ⋆ ).
Adverse Event AMI GIB ALI AKI
model 100 67 50 56
nb signals 9 10 26 25
positive controls 1 5 20 12
negative controls 1 0 0 0
time 1 3 3 5
mγ⋆ 45 629 554 1024
The computing time has been strongly reduced by using the expression of the log-likelihood given in
Appendix A. For example, by considering the best model resulting of the adverse event AMI where 9 vari-
ables have a non-zero coefficient, the database can be reduced to mγ⋆ = 45 unique weighted individuals
(see Appendix A). Moreover, since many different initialisations allow to find γ⋆, the number of initial-
isations (set at 100 during the experiment) could be reduced. Finally, the list of the detected signals are
presented in Appendix B.
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4.5 Specific comments about the Lasso
We have seen that the Lasso obtains poor results when the penalty is determined according to the mis-
classification error. Caster et al. (2010) suggest to set the same penalty value for all the adverse events.
Moreover, they use a disproportionality measure to evaluate the number of signals and thus to deduce the
penalty value.
In order to investigate the Lasso approach features, we build a sequence of penalties to obtain different
numbers of signals with the Lasso. The numbers of positive and negative controls resulting for each penalty
values are indicated by the black lines of Figure 1.
Fig. 1 Rates of positive and negative controls obtained by the Lasso with different penalities black curve) and obtained
by the model maximizing the BIC criterion (red dots).
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The results related to the model maximizing the BIC criterion are indicated by red dots. On Figure 1, it is
very hard to find a penalty value from where results obtained a better trade off between the positive and the
negative controls. If, for the same number of signals (70) as obtained by Algorithm 1, the Lasso approach
presents slightly better performances, the corresponding penalty value does not result from an optimizing
procedure. These figures can not be plotted in reality, since the nature of the signals are unknown. Thus,
it seems more efficient to select the model maximizing the BIC criterion than to use a Lasso regression.
Indeed, the penalty calibration is very difficult and the results related to the ”best” penalty value are similar
to those related to the model maximizing the BIC criterion. Moreover, this penalty value is not accessible
in practice.
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5 Discussion
In this paper, we have proposed a method for analysing individual spontaneous reporting databases, which
also avoids the drawbacks of the disproportionality-based measures (co-prescription and masking effects).
The signal detection is led throughout parsimonious logistic regressions whose sparsity degree is assessed
as a model selection challenge. Therefore, we avoid the use of Lasso-type method that requires the chal-
lenging calibration of penalty. The combinatorial problem of model selection is bypassed by Metropolis-
Hastings binary space sampling.
Despite to the difficulties for evaluating pharmacovigilance methods, the OMOP reference set of Ryan et al.
(2013) gives us the opportunity to compare the proposed method to the reference approaches on real data.
On these data, it appears to be relevant for the signal detection issue. However, many signals are not de-
tected by our method. So, we conclude that this method should be used in parallel to existing measures in
pharmacovigilance.
The proposed approach can manage the whole French pharmacovigilance database which consists of
n = 219, 340 individual notifications, p = 2, 114 drugs and d = 4, 257 adverse events. We have shown
that the dimension of the model space is defined by the number of drugs verifying (5). Figure 2 presents
the evolution of this number according to the headcount of the adverse events.
Fig. 2 Evolution of the number of drugs verifying (5) according to the headcount of the adverse event.
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In the whole database, 75% of the adverse events can be associated to less than 42 drugs. For the adverse
events which have less than 12 drugs verifying (5), we advise to use an exhaustive approach consisting of
computing the BIC criterion for each competing models in Γ. The model selection on the whole French
pharmacovigilance database is achieved at the cost of several days of computing time. The proposed
approach can thus be used to investigate targeted adverse events. Finally, a preliminary drug selection
could provide a reducing of computing time.
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A Weighted form of the adverse event log-likelihood
Obviously, the coordinates of xi impacting the log-likelihood value are those belonging to Dγ . For each
observation xi, we denote by xγi ∈ B|γ|, where |γ| =
∑p
j=1 γj , the vector containing the elements of xi
impacting the log-likelihood (i.e. the vector composed with the elements of xi such as index belongs to
Dγ). Thus, for each j = 1, . . . , |γ|:
x
γ
ij = xij0 with j0 = min

j′ :
j′∑
j′′=1
γj′′ = j

 . (14)
Moreover, many individual profiles (xγi , yi) occur many times in the database. We denote by mγ the
number of different profiles impacting the log-likelihood of model γ. The profile i is denoted by (x˜γi , y˜
γ
i )
and its weight is denoted by wγi . Thus, (3) is given by
ℓn
(
y | x,γ,β
)
=
mγ∑
i=1
w
γ
i y˜
γ
i
(
β0 +
|γ|∑
j=1
βj x˜
γ
ij
)
− wi ln
[
1 + exp
(
β0 +
|γ|∑
j=1
βj x˜
γ
ij
)]
, (15)
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where βγj is the j-th element which is not zero in β, so for each j = 1, . . . , |γ|:
β
γ
j = βj0 with j0 = min

j′ :
j′∑
j′′=1
γj′′ = j

 . (16)
In practice, it is often more numerically efficient to compute the adverse event log-likelihood by us-
ing (15) than by using (3).
B Signals detected by the proposed methods
Table 7 presents the couples between a drug and an adverse events detected by the proposed method.
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Table 7 List of the signals detected by the proposed method.
Adverse event ATC Headcount βj Omop control
AMI L03AB07 7 2.92 unknown
ALI J05AE09 36 2.85 positive
AMI N02CC03 6 2.6 positive
ALI L01BB03 8 2.51 positive
AKI M01AE09 46 2.27 unknown
ALI C02KX01 65 2.25 positive
AMI M01AH01 21 2.05 unknown
AMI L01BC05 10 1.85 unknown
GIB M01AC01 138 1.84 positive
AMI J05AF05 92 1.84 unknown
GIB B01AC04 523 1.77 positive
AKI J05AF07 144 1.76 unknown
GIB B01AC07 31 1.67 unknown
AKI C09AA05 353 1.66 unknown
AKI C09AA03 165 1.66 positive
AKI C09CA08 35 1.65 positive
ALI L02BB01 10 1.61 positive
ALI J05AG01 297 1.55 positive
ALI J02AC03 117 1.54 positive
AKI C09AA02 146 1.51 positive
GIB M01AE03 276 1.5 positive
AKI C09AA10 38 1.49 unknown
AKI N05AD08 10 1.48 unknown
AKI L04AD01 91 1.38 positive
GIB M01AE02 52 1.34 positive
ALI J01XE01 52 1.33 positive
ALI J04AB02 538 1.31 positive
AKI C09CA07 34 1.31 positive
AKI M01AE03 250 1.31 positive
AMI L04AB02 13 1.29 unknown
AKI L01BA01 129 1.28 unknown
ALI A03AX13 26 1.25 unknown
ALI A07EC01 71 1.24 unknown
AKI L01BC05 57 1.18 unknown
AKI C09CA06 139 1.16 positive
GIB M01AH01 98 1.15 unknown
ALI J02AC02 22 1.15 positive
AMI B01AC04 24 1.14 unknown
ALI J04AC01 359 1.08 positive
AKI C09AA06 25 1.06 unknown
AKI C09AA01 61 1.02 positive
ALI N03AF01 248 0.99 positive
AKI M01AE02 43 0.99 positive
ALI D01AE15 77 0.98 positive
AMI J05AF02 30 0.98 negative
ALI L03AB07 27 0.98 positive
ALI J02AC01 188 0.97 positive
ALI G03CA03 76 0.96 unknown
AKI J04AB02 104 0.96 unknown
GIB A12BA01 155 0.94 positive
AKI J01MA02 147 0.87 unknown
AMI J05AF06 44 0.83 unknown
ALI L01BA01 186 0.81 positive
AKI M04AA01 220 0.77 positive
AKI C03AA03 430 0.73 positive
AKI M01AH01 72 0.68 unknown
GIB C08DB01 81 0.63 unknown
AKI A12BA01 154 0.62 unknown
ALI A10BF01 36 0.61 unknown
AKI M01AC01 47 0.59 positive
ALI N03AG01 298 0.56 positive
ALI J01MA06 60 0.54 positive
ALI N05BA05 147 0.53 unknown
ALI J05AF07 177 0.49 positive
ALI M04AA01 216 0.45 positive
AKI J01MA01 109 0.43 unknown
GIB C08CA01 126 0.37 unknown
ALI N06AB04 117 0.36 unknown
GIB C09AA05 148 0.35 unknown
ALI M01AE03 200 0.31 unknown
ALI J01MA02 202 0.31 positive
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